Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study

Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Agnese Ozolina, Janis Nemme, Arturs Ozolins, Lars J. Bjertnæs, Indulis Vanags, Janis Gardovskis, Ludmila Viksna, Angelika Krumina
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2018.00253/full
id doaj-c7a9cb7892a146069ad3bf0e0fbdd15e
record_format Article
spelling doaj-c7a9cb7892a146069ad3bf0e0fbdd15e2020-11-24T21:04:39ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-09-01510.3389/fmed.2018.00253399593Fibrinolytic System Changes in Liver Surgery: A Pilot Observational StudyAgnese Ozolina0Agnese Ozolina1Janis Nemme2Arturs Ozolins3Arturs Ozolins4Lars J. Bjertnæs5Indulis Vanags6Indulis Vanags7Janis Gardovskis8Janis Gardovskis9Ludmila Viksna10Angelika Krumina11Department of Anesthesiology, Orto Clinic, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Anesthesiology and Intensive Care Unit, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Surgery, Pauls Stradins Clinical University Hospital, Riga, LatviaAnesthesia and Critical Care Research Group, Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, NorwayRiga Stradins University, Riga, LatviaDepartment of Anesthesiology and Intensive Care Unit, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Surgery, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaRiga Stradins University, Riga, LatviaIntroduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05.Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002).Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients.https://www.frontiersin.org/article/10.3389/fmed.2018.00253/fullfibrinolysisliver surgerytissue plasminogen activatort-PAplasminogen activator inhibitor type 1PAI-1
collection DOAJ
language English
format Article
sources DOAJ
author Agnese Ozolina
Agnese Ozolina
Janis Nemme
Arturs Ozolins
Arturs Ozolins
Lars J. Bjertnæs
Indulis Vanags
Indulis Vanags
Janis Gardovskis
Janis Gardovskis
Ludmila Viksna
Angelika Krumina
spellingShingle Agnese Ozolina
Agnese Ozolina
Janis Nemme
Arturs Ozolins
Arturs Ozolins
Lars J. Bjertnæs
Indulis Vanags
Indulis Vanags
Janis Gardovskis
Janis Gardovskis
Ludmila Viksna
Angelika Krumina
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
Frontiers in Medicine
fibrinolysis
liver surgery
tissue plasminogen activator
t-PA
plasminogen activator inhibitor type 1
PAI-1
author_facet Agnese Ozolina
Agnese Ozolina
Janis Nemme
Arturs Ozolins
Arturs Ozolins
Lars J. Bjertnæs
Indulis Vanags
Indulis Vanags
Janis Gardovskis
Janis Gardovskis
Ludmila Viksna
Angelika Krumina
author_sort Agnese Ozolina
title Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_short Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_full Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_fullStr Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_full_unstemmed Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
title_sort fibrinolytic system changes in liver surgery: a pilot observational study
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2018-09-01
description Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05.Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002).Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients.
topic fibrinolysis
liver surgery
tissue plasminogen activator
t-PA
plasminogen activator inhibitor type 1
PAI-1
url https://www.frontiersin.org/article/10.3389/fmed.2018.00253/full
work_keys_str_mv AT agneseozolina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT agneseozolina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT janisnemme fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT artursozolins fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT artursozolins fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT larsjbjertnæs fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT indulisvanags fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT indulisvanags fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT janisgardovskis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT janisgardovskis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT ludmilaviksna fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
AT angelikakrumina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy
_version_ 1716770358512582656